Insider Selling: PerkinElmer, Inc. (PKI) Insider Sells 2,324 Shares of Stock

PerkinElmer, Inc. (NYSE:PKI) insider Andrew Okun sold 2,324 shares of the business’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $75.44, for a total transaction of $175,322.56. Following the completion of the sale, the insider now owns 8,876 shares of the company’s stock, valued at $669,605.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Andrew Okun also recently made the following trade(s):

  • On Monday, February 5th, Andrew Okun sold 2,273 shares of PerkinElmer stock. The shares were sold at an average price of $77.86, for a total transaction of $176,975.78.
  • On Friday, December 15th, Andrew Okun sold 12,680 shares of PerkinElmer stock. The shares were sold at an average price of $72.00, for a total transaction of $912,960.00.

PerkinElmer, Inc. (PKI) traded up $0.77 on Friday, reaching $72.83. 1,212,966 shares of the company’s stock traded hands, compared to its average volume of 769,324. The company has a current ratio of 1.27, a quick ratio of 0.90 and a debt-to-equity ratio of 0.72. PerkinElmer, Inc. has a 12 month low of $53.63 and a 12 month high of $84.49. The stock has a market capitalization of $8,351.76, a P/E ratio of 25.95, a P/E/G ratio of 1.75 and a beta of 0.76.

PerkinElmer (NYSE:PKI) last released its quarterly earnings data on Thursday, January 25th. The medical research company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.03. PerkinElmer had a net margin of 12.97% and a return on equity of 13.30%. The company had revenue of $641.63 million during the quarter, compared to the consensus estimate of $619.14 million. During the same period in the previous year, the firm earned $0.83 earnings per share. PerkinElmer’s revenue for the quarter was up 13.2% on a year-over-year basis. equities research analysts anticipate that PerkinElmer, Inc. will post 3.52 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 10th. Shareholders of record on Friday, April 13th will be paid a dividend of $0.07 per share. The ex-dividend date is Thursday, April 12th. This represents a $0.28 annualized dividend and a yield of 0.38%. PerkinElmer’s dividend payout ratio is currently 10.61%.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Cutler Group LP lifted its position in shares of PerkinElmer by 845.7% during the fourth quarter. Cutler Group LP now owns 2,237 shares of the medical research company’s stock worth $163,000 after purchasing an additional 2,537 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its position in shares of PerkinElmer by 53.8% during the fourth quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 2,228 shares of the medical research company’s stock worth $170,000 after purchasing an additional 779 shares in the last quarter. Waldron LP acquired a new position in shares of PerkinElmer during the third quarter worth $200,000. Seaward Management Limited Partnership acquired a new position in shares of PerkinElmer during the third quarter worth $202,000. Finally, Signition LP acquired a new position in shares of PerkinElmer during the fourth quarter worth $207,000. Institutional investors own 90.98% of the company’s stock.

A number of equities research analysts recently issued reports on PKI shares. Bank of America upgraded shares of PerkinElmer from an “underperform” rating to a “neutral” rating and set a $78.00 target price for the company in a report on Tuesday, December 19th. Robert W. Baird boosted their target price on shares of PerkinElmer from $75.00 to $78.00 and gave the company an “outperform” rating in a report on Friday, November 3rd. Zacks Investment Research upgraded shares of PerkinElmer from a “hold” rating to a “buy” rating and set a $86.00 target price for the company in a report on Monday, January 8th. Evercore ISI started coverage on shares of PerkinElmer in a report on Wednesday, January 3rd. They issued an “in-line” rating and a $77.00 target price for the company. Finally, Jefferies Group restated a “hold” rating and issued a $70.00 target price on shares of PerkinElmer in a report on Friday, October 20th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and six have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $76.85.

WARNING: “Insider Selling: PerkinElmer, Inc. (PKI) Insider Sells 2,324 Shares of Stock” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/02/09/insider-selling-perkinelmer-inc-pki-insider-sells-2324-shares-of-stock.html.

About PerkinElmer

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Insider Buying and Selling by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply